echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The flu Terminator? New study finds 10,000 T-cells! Universal influenza vaccine is out!

    The flu Terminator? New study finds 10,000 T-cells! Universal influenza vaccine is out!

    • Last Update: 2021-02-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, scientists claimed to have discovered immune cells that can fight all known influenza viruses, in what has been hailed as a major breakthrough that could help develop a universal one-off vaccine against multiple diseases.
    flu epidemic causes hundreds of deaths each year. Because influenza viruses mutate rapidly, the composition of the vaccine must be updated quickly and only for a short period of time.
    from Australia say they have found that about half of the world's population has a lethal T-cell that is effective against all known influenza viruses. This means that the cells could be used to develop an all-ener likely flu vaccine, whose composition does not need to be adjusted annually and is effective even in people who are born without them.
    " flu virus continues to rapidly mutate to evade recognition by our immune system, and these mutations are so large that it is impossible to predict and develop a vaccine to prevent the next flu pandemic. Marios Koutsakos, from the Doherty Institute at the University of Melbourne, said.
    T-cell is a type of white blood cell that is responsible for walking the whole body against abnormal mutations and infections. They are necessary for the body's immunity to a range of invading viruses and bacteria. So-called lethal T cells are unique because they can directly target and kill other infected cells.
    Koutsakos and his colleagues used mass spectromety to identify the same structure that all strains have, so they realized that killer T-cells could be effective against mutations in multiple influenza viruses.
    is extremely dangerous for the elderly, children, immunodeficiency, and some people who do not have immunity to fight the disease. The team has patented their findings, and researchers say they hope the study will help them develop a generic flu vaccine to reduce the impact of pandemic and seasonal influenza on the world. (Bio Valley)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.